Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRIM24 | O15164 | 2/20 | 0.52 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.40 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14841031 | 0.86 | TRIM24 (0.50) | TRIM24TRIM33KMT2AMEN1TDP1 | |
| SCHEMBL29773795 | 0.85 | TRIM24 (0.61) | TRIM24TRIM33KMT2AMEN1TDP1 | |
| SCHEMBL29285316 | 0.85 | TRIM24 (0.48) | TRIM24TRIM33KMT2AMEN1TDP1 | |
| Water SCHEMBL20534686 | 0.85 | TRIM24 (0.48) | TRIM24TRIM33KMT2AMEN1TDP1 | |
| SCHEMBL19154063 | 0.83 | TRIM24 (0.47) | TRIM24TRIM33KMT2ATDP1LMNA | |
| SCHEMBL3719104 | 0.83 | POLB (0.48) | TRIM24TRIM33KMT2AALDH1A1 | |
| SCHEMBL11437932 | 0.83 | TRIM24 (0.56) | TRIM24TRIM33KMT2AMEN1TDP1 | |
| SCHEMBL30479918 | 0.83 | TRIM24 (0.47) | TRIM24TRIM33KMT2AMEN1TDP1 | |
| SCHEMBL15330922 | 0.83 | ERN1 (0.47) | TRIM24TRIM33TDP1ALDH1A1SMN1; SMN2 | |
| SCHEMBL2635636 | 0.82 | PTGS2 (0.49) | TRIM24TRIM33KMT2AMEN1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030176709-A1 | Vinyl-phenyl pyridine monomers and polymers prepared thereform | KWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY | 2003-09-18 | — | — | US | claimed |
| US-6545159-B2 | Suzuki coupling reaction of vinyl-phenylboronic acid and 2-bromopyridine in presence of alkali metallic base and tetrakis/triphenylphosphine/palladium to form styrenepyridine monomer | KWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2003-04-08 | — | — | US | claimed |
| US-20020198346-A1 | Vinyl-phenyl pyridine monomers and polymers prepared thereform | KWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY | 2002-12-26 | — | — | US | claimed |
| US-20260070901-A1 | NOVEL COMPOUNDS AS CK2 INHIBITORS | CAMBRIDGE ENTPR LTD (GB) | 2026-03-12 | — | — | US | disclosed |
| EP-2906558-B1 | SODIUM CHANNEL BLOCKERS, PREPARATION METHOD THEREOF AND USE THEREOF | DAE WOONG PHARMA (KR) | 2020-09-02 | — | — | EP | disclosed |
| EP-3444249-B1 | SODIUM CHANNEL BLOCKERS, PREPARATION METHOD THEREOF AND USE THEREOF | DAE WOONG PHARMA (KR) | 2020-05-13 | — | — | EP | disclosed |
| EP-3444249-A1 | SODIUM CHANNEL BLOCKERS, PREPARATION METHOD THEREOF AND USE THEREOF | Daewoong Pharmaceutical Co., Ltd. (KR) | 2019-02-20 | — | — | EP | disclosed |
| US-9376429-B2 | Sodium channel blockers, preparation method thereof and use thereof | DAEWOONG PHARMACEUTICAL CO., LTD. (KR) | 2016-06-28 | — | — | US | disclosed |
| US-20150336944-A1 | Sodium Channel Blockers, Preparation Method Thereof and Use Thereof | IN THERAPEUTICS (KR) | 2015-11-26 | — | — | US | disclosed |
| US-20150266864-A1 | HETEROAROMATIC COMPOUNDS, METHOD FOR PREPARING THE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, USES AND METHOD FOR TREATING ACUTE AND CHRONIC PAIN | CRISTÁLIA PRODUTOS QUÍMICOS FARMACÊUTICOS LTDA (BR) | 2015-09-24 | — | — | US | disclosed |
| EP-2906558-A1 | SODIUM CHANNEL BLOCKERS, PREPARATION METHOD THEREOF AND USE THEREOF | Daewoong Pharmaceutical Co., Ltd. (KR) | 2015-08-19 | — | — | EP | disclosed |
| US-20030176709-A1 | Vinyl-phenyl pyridine monomers and polymers prepared thereform | KWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY | 2003-09-18 | — | — | US | disclosed |
| US-6545159-B2 | Suzuki coupling reaction of vinyl-phenylboronic acid and 2-bromopyridine in presence of alkali metallic base and tetrakis/triphenylphosphine/palladium to form styrenepyridine monomer | KWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2003-04-08 | — | — | US | disclosed |
| US-20020198346-A1 | Vinyl-phenyl pyridine monomers and polymers prepared thereform | KWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY | 2002-12-26 | — | — | US | disclosed |
| EP-1109804-A1 | CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREFOR | Millennium Pharmaceuticals, Inc. (US) | 2001-06-27 | — | — | EP | disclosed |
| WO-2000014086-A1 | CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREFOR | MILLENIUM PHARMACEUTICALS, INC. (US) | 2000-03-16 | — | — | WO | disclosed |
| EP-0148826-A1 | FUNGICIDAL, HERBICIDAL AND PLANT GROWTH REGULATING PYRIDYL-CONTAINING ETHERS | CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) | 1985-07-24 | — | — | EP | disclosed |
| WO-1985000289-A1 | FUNGICIDAL, HERBICIDAL AND PLANT GROWTH REGULATING PYRIDYL-CONTAINING ETHERS | CHEVRON RESEARCH COMPANY (US) | 1985-01-31 | — | — | WO | disclosed |
| US-4407806-A | PRE- AND POSTEMERGENCE HERBICIDES | CHEVRON RESEARCH COMPANY (US) | 1983-10-04 | — | — | US | disclosed |
| US-4376769-A | Substituted imidazo thiazoles thiazines, thiazepines and thiazocines | SCHERING CORPORATION (US) | 1983-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150266864-A1 | HETEROAROMATIC COMPOUNDS, METHOD FOR PREPARING THE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, USES AND METHOD FOR TREATING ACUTE AND CHRONIC PAIN | TRPV1, AP1G1, INA | TRIM24 3740/4885TRIM33 4080/4885KMT2A 2470/4885 |
| US-20150336944-A1 | Sodium Channel Blockers, Preparation Method Thereof and Use Thereof | SCN7A, SCN1A, SCN5A | TRIM24 4199/4885TRIM33 4622/4885KMT2A 2688/4885 |
| US-20260070901-A1 | NOVEL COMPOUNDS AS CK2 INHIBITORS | CSNK1A1, CSNK2A3, CSNK1G1 | TRIM24 1597/4885TRIM33 3449/4885KMT2A 250/4885 |
| US-20020198346-A1 | Vinyl-phenyl pyridine monomers and polymers prepared thereform | VAT1, PBRM1, THEM6 | TRIM24 1028/4885TRIM33 1487/4885KMT2A 1924/4885 |
| US-20030176709-A1 | Vinyl-phenyl pyridine monomers and polymers prepared thereform | VAT1, PBRM1, THEM6 | TRIM24 1028/4885TRIM33 1487/4885KMT2A 1924/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.